Usage of silver nanoparticles to restore moxifloxacin efficacy for fluoroquinolone-resistant M. tuberculosis cultures.
Abstract
BACKGROUND: Fluoroquinolones are used for the complex treatment of mono-, poly-, and multi-resistant Tuberculosis (TB) and are the most efficient among resistant TB treatment drugs. Disease caused by fluoroquinolone-resistant TB strains, especially pre-extensive TB (pre-XDR) and extensive (XDR) forms are extremely hard to manage, and treatment efficacy is quite low. With the revitalization and extension of resistant TB drugs, one of the main research domains is to study resistance inhibitors aimed at restoring the efficacy of main and priority anti-TB medications. The antibacterial properties of silver nanoparticles (AgNPs) against resistant strains responsible for various infectious diseases are supported by extensive experimental data. There are a few publications regarding the effectiveness of silver nanoparticles on resistance inhibition of TB strains, however, its action on fluoroquinolone-resistant TB strains is unexplored.
AIM: The study aimed to investigate the in vitro restoration of the anti-TB efficacy of Moxifloxacin (Mfx) using AgNPs.
METHODS: Nanocomposite- standard dose of Mfx and 20 nm silver nanoparticles (AgNPs) suspension solution of 6 different concentrations: 0.25%; 0.5%; 1%; 2.5%; 5% and 10%, were supplemented to 70 moxifloxacin-resistant mycobacterium tuberculosis isolates. The control arm consisted of 70 fluoroquinolone (Mfx)-resistant Mycobacterium tuberculosis (FQ/ R-MTB) isolates and AgNPs suspension with identical concentrations. The inhibitory…
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.